AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionFounders Capital Management
Latest Disclosed Ownership24,695 shares
Latest Disclosed Value $ 5,370,916
Founders Capital Management reports 0.31% decrease in ownership of 4AB / AbbVie Inc.

On April 21, 2026 - Founders Capital Management filed a 13F-HR form disclosing ownership of 24,695 shares of AbbVie Inc. (BG:4AB) valued at $5,370,916 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 24,771 shares of AbbVie Inc.. This represents a change in shares of -0.31% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ABBVIE COM 00287Y109 24,695 -76 -0.31 5,371 -5.11 2.6221
2026-01-15 2025-12-31 13F ABBVIE COM 00287Y109 24,771 -125 -0.50 5,660 -1.82 2.9391
2025-11-13 2025-09-30 13F ABBVIE COM 00287Y109 24,896 -277 -1.10 5,764 23.37 3.0539
2025-07-18 2025-06-30 13F ABBVIE COM 00287Y109 25,173 -148 -0.58 4,673 -11.93 2.8007
2025-04-08 2025-03-31 13F ABBVIE COM 00287Y109 25,321 -6,208 -19.69 5,305 -5.30 3.4326
2025-01-13 2024-12-31 13F ABBVIE COM 00287Y109 31,529 -1,090 -3.34 5,603 -13.03 3.5469
2024-10-07 2024-09-30 13F ABBVIE COM 00287Y109 32,619 -239 -0.73 6,442 14.30 3.9223
2024-07-10 2024-06-30 13F ABBVIE COM 00287Y109 32,858 -622 -1.86 5,636 -7.56 3.6519
2024-04-10 2024-03-31 13F ABBVIE COM 00287Y109 33,480 -297 -0.88 6,097 16.47 4.1209
2024-01-08 2023-12-31 13F ABBVIE COM 00287Y109 33,777 -364 -1.07 5,234 2.85 3.8031
2023-10-10 2023-09-30 13F ABBVIE COM 00287Y109 34,141 -1,484 -4.17 5,089 6.04 3.8861
2023-07-07 2023-06-30 13F ABBVIE COM 00287Y109 35,625 47 0.13 4,800 95,880.00 3.4910
2023-04-12 2023-03-31 13F ABBVIE COM 00287Y109 35,578 -372 -1.03 6 0.00 4.3358
2023-01-09 2022-12-31 13F ABBVIE COM 00287Y109 35,950 9 0.03 6 -99.90 4.3660
2022-10-06 2022-09-30 13F ABBVIE COM 00287Y109 35,941 -276 -0.76 4,824 -13.03 3.9365
2022-07-20 2022-06-30 13F ABBVIE COM 00287Y109 36,217 -2,315 -6.01 5,547 6.33 4.3722
2022-04-07 2022-03-31 13F ABBVIE COM 00287Y109 38,532 0 0.00 5,217 0.00 3.3445
2022-01-21 2021-12-31 13F ABBVIE COM 00287Y109 38,532 -279 -0.72 5,217 24.60 3.3445
2021-10-12 2021-09-30 13F ABBVIE COM 00287Y109 38,811 -3,017 -7.21 4,187 -11.14 2.8702
2021-07-15 2021-06-30 13F ABBVIE COM 00287Y109 41,828 -280 -0.66 4,712 3.40 3.0714
2021-06-09 2021-03-31 13F/A-1 ABBVIE COM 00287Y109 42,108 -2,090 -4.73 4,557 -3.78 3.2435
2021-06-07 2021-03-31 13F ABBVIE COM 00287Y109 42,108 -2,090 6 0.0658
2021-01-12 2020-12-31 13F ABBVIE COM 00287Y109 44,198 -5,926 -11.82 4,736 24.01 3.3491
2020-04-22 2020-03-31 13F ABBVIE COM 00287Y109 50,124 -5,879 -10.50 3,819 -22.99 3.9608
2020-01-24 2019-12-31 13F ABBVIE COM 00287Y109 56,003 8,960 19.05 4,959 39.22 3.7532
2019-10-10 2019-09-30 13F ABBVIE COM 00287Y109 47,043 2,910 6.59 3,562 11.00 2.8491
2019-07-11 2019-06-30 13F ABBVIE COM 00287Y109 44,133 -47 -0.11 3,209 -9.86 2.8301
2019-04-17 2019-03-31 13F ABBVIE COM 00287Y109 44,180 215 0.49 3,560 -12.16 3.3377
2019-01-14 2018-12-31 13F ABBVIE COM 00287Y109 43,965 -220 -0.50 4,053 -3.02 4.3264
2018-10-05 2018-09-30 13F ABBVIE COM 00287Y109 44,185 -70 -0.16 4,179 1.93 3.4467
2018-07-09 2018-06-30 13F ABBVIE COM 00287Y109 44,255 -739 -1.64 4,100 -3.73 3.5990
2018-04-09 2018-03-31 13F ABBVIE COM 00287Y109 44,994 -1,000 -2.17 4,259 -4.25 3.5864
2018-01-22 2017-12-31 13F ABBVIE COM 00287Y109 45,994 -690 -1.48 4,448 7.23 3.6888
2017-10-17 2017-09-30 13F ABBVIE COM 00287Y109 46,684 330 0.71 4,148 23.42 3.4378
2017-07-19 2017-06-30 13F ABBVIE COM 00287Y109 46,354 1,275 2.83 3,361 14.44 2.9783
2017-05-09 2017-03-31 13F ABBVIE COM 00287Y109 45,079 45,079 2,937 2.6400
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.